Bridget E. Bunner

Array ( [id] => 8323524 [patent_doc_number] => 20120195905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO DLL4 AND USES THEREOF 524' [patent_app_type] => utility [patent_app_number] => 13/446637 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 94120 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755257 [patent_doc_number] => 20130089562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'METHODS OF TREATING LIVER CONDITIONS USING NOTCH2 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/441753 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 26538 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642217 [patent_doc_number] => 09663573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Methods of treating liver conditions using Notch2 antagonists' [patent_app_type] => utility [patent_app_number] => 14/349005 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 96 [patent_no_of_words] => 26598 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892199 [patent_doc_number] => 20130165383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'APO-2 LIGAND/TRAIL VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/441682 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 29468 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269676 [patent_doc_number] => 20140024594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY' [patent_app_type] => utility [patent_app_number] => 14/008130 [patent_app_country] => US [patent_app_date] => 2012-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 33749 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406672 [patent_doc_number] => 20150291681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING NOTCH ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/388598 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 23776 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358632 [patent_doc_number] => 20120213790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/424692 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9122 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13424692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278905 [patent_doc_number] => 20120172776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'HEMOSTATIC TEXTILE' [patent_app_type] => utility [patent_app_number] => 13/411024 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10081 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13411024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575257 [patent_doc_number] => 08765671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Methods and compositions for modulation of blood-neural barrier' [patent_app_type] => utility [patent_app_number] => 13/407270 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17679 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13407270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323502 [patent_doc_number] => 20120195914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'ALDOSTERONE INDUCED ELASTIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/405744 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9276 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240308 [patent_doc_number] => 20120149044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY' [patent_app_type] => utility [patent_app_number] => 13/405166 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31341 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192012 [patent_doc_number] => 20130331326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'METHOD OF INDUCING HEMATOPOIETIC RECONSTRUCTION' [patent_app_type] => utility [patent_app_number] => 14/000679 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11694 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617654 [patent_doc_number] => 20130022966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Methods of Treating Cancer Using Notch Pathway Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/399556 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12335 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602664 [patent_doc_number] => 20140199347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'ADJUVANT COMPOSITIONS WITH 4-1BBL' [patent_app_type] => utility [patent_app_number] => 13/983940 [patent_app_country] => US [patent_app_date] => 2012-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12165 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453734 [patent_doc_number] => 20120264680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'REGULATION OF ENERGY METABOLISM AND OBESITY BY MODULATING B CELL ACTIVATING FACTOR (BAFF, BLYS) OR BAFF SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/364776 [patent_app_country] => US [patent_app_date] => 2012-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11769 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209028 [patent_doc_number] => 20120128697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 13/358425 [patent_app_country] => US [patent_app_date] => 2012-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8056 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128697.pdf [firstpage_image] =>[orig_patent_app_number] => 13358425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9698577 [patent_doc_number] => 20140248260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/979104 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 29362 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10142260 [patent_doc_number] => 09175059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Anticancer fusion protein comprising trail and a growth factor receptor inhibitor' [patent_app_type] => utility [patent_app_number] => 13/978090 [patent_app_country] => US [patent_app_date] => 2012-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 26554 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055981 [patent_doc_number] => 20120077733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTAGONISTS AGAINST INTERACTION OF PF4 AND RANTES' [patent_app_type] => utility [patent_app_number] => 13/315088 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077733.pdf [firstpage_image] =>[orig_patent_app_number] => 13315088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568660 [patent_doc_number] => 20140186373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'ANTIBODY FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/991984 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11818 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991984 [rel_patent_id] =>[rel_patent_doc_number] =>)